News & Blog
Every day, we hear about the staggering toll of the opioid overdose crisis. This is particularly salient in Philadelphia, which has one of the highest overdose death rates among major U.S. cities. Despite effective medications for opioid use disorder, such as buprenorphine and methadone, few people receive treatment. The ongoing challenge is to expand access to these lifesaving treatments […]
CHERISH Investigators from the University of Pennsylvania Leonard Davis Institute Zachary Meisel, Julia Mitchell, Daniel Polsky and Janet Weiner published a new study in Substance Abuse Treatment Prevention and Policy that describes how eighteen policy makers involved in the delivery of health services engage with substance use disorder (SUD) research to inform policy.
Naloxone is an opioid antagonist rescue medication that reverses the effects of an opioid overdose, and thus a critical tool to prevent fatal opioid overdoses. CHERISH Investigators Drs. Sean Murphy, Jake Morgan, and Bruce Schackman, and CHERISH staff member Philip Jeng, MS predicted pharmacy sales following conversion of naloxone to over-the-counter (OTC) in a new […]
Purdue Pharma’s 2010 reformulation of OxyContin as an abuse-resistant pill was supposed to be a breakthrough in battling the burgeoning opioid epidemic. Purdue executives and policymakers touted the reformulation as a way to dampen the supply of abusable drugs, thereby reducing opioid addiction and death. Nearly a decade later, it appears that the policy had several serious […]
The intersection of criminal justice-involved populations and people who use substances makes criminal justice outcomes particularly significant for estimating the economic impact of substance use disorder interventions. New National Institute on Drug Abuse (NIDA) HEAL initiative funding opportunities in response to the opioid crisis include integrated studies that will develop, test, and validate evidence-based approaches […]
The National Institute on Drug Abuse (NIDA) has issued a request for application for the Justice Community Opioid Innovation Network (JCOIN) as part of the HEAL Initiative. Applications are due February 28, 2019. JCOIN will establish a network of clinical research centers to rapidly conduct studies on quality care for opioid use disorders in the justice […]